Skip to main content

Month: August 2020

How to Purchase Your Own Dream Bike on EMI

Have you been eyeing a bike for a long time? Stop dreaming about it and make it yours. Now, you can own a bike without hurting your wallet. Hero FinCorp offers a loan for the purchase of a bike on EMI, which makes bike financing easy and simple. Irrespective of the type and brand of bike you wish to own, Hero FinCorp can turn your dream into a reality. You need to start by shortlisting the bikes you wish to purchase. You can then take a test drive in them and decide whether the bike is ideal for you or not. The loan is available for economy bikes as well as sports bikes. If you are someone who likes to go on adventures in the hills, choose a high capacity bike. And if you are purchasing only for your daily commute, simply choose an economy model that has all the features you are looking for. Hero FinCorp is one of the most reliable and...

Continue reading

Investam-HK: Nasdaq fell short back to 10,000 while Gold remained strong, other major indices are up

Stocks rallied mixed this Monday session as investors focus on the reports of positive earnings results and upcoming government’s stimulus package. Nasdaq however lost its pace and is down again at 10k range. Major contributors of the dipped are tech giants Microsoft and Facebook who slid around 2% while Amazon fell by 0.6%. Gold index is down for four consecutive days now but remained at $2,000 an ounce while crude oils are up. Here are the main movements from the Global market; Stocks – The Dow Jones Industrial Average advances with 357 points change or 1.3% closing its price around 27,791.44. Its 6th day positive gained for this month.– The S&P 500 climbed up with 0.3% to 3,360.47, just as the market closed by 4:00 in the afternoon New York time.– Nasdaq Composite fell big time losing about 0.4% down to 10,968.36.–...

Continue reading

Kuros Biosciences Reports Results for First Half 2020

  Financial and Operational HighlightsCHF 16.0 million cash & cash equivalents, trade and other receivables as at June 30, 2020Revenues increased to CHF 1.3 million driven by strong MagnetOs sales, up 42% versus H1 2019Net operating costs of CHF 7.5 million led by higher marketing expensesSeveral trial sites activated for the Fibrin-PTH phase II clinical study, ready to enroll patientsStrengthened Fibrin-PTH IP estate with U.S. patent covering PTH containing matrices for spinal fusionMagnetOs preclinical data demonstrate superiority to market-leading synthetic bone grafts in spinal fusionPositive clinical outcomes from investigator-led clinical study of MagnetOsZURICH, Switzerland, Aug. 12, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences, a leader in next generation bone graft technologies, today reported its results for the first...

Continue reading

Addex Reports 2020 Half Year Financial Results and Provides Corporate Update

Geneva, Switzerland, August 12, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its second quarter and half year financial results for the periods ended June 30, 2020 and provided an update on corporate activities.H1 2020 Operating Highlights:

Continue reading

Number of shares and voting rights of Innate Pharma as at August 1, 2020

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as at August 1, 2020:(1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. The total number of theoretical voting rights includes (i) voting rights attached to AGAP 2016...

Continue reading

Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 1er août 2020

Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (la « Société » – Euronext Paris : FR0010331421 – IPH ; Nasdaq : IPHA) publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 1er août 2020 :                                                                                                 (1) Le nombre de droits de vote théoriques (ou droits de vote « bruts ») sert de base de calcul pour les franchissements de seuils. Conformément à l’article 223-11 du Règlement Général de l’AMF, ce nombre est calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote. Le nombre de droits de vote théoriques comprend...

Continue reading

Awilco Drilling PLC: Awilco Drilling Reports Q2 2020 Results

Awilco Drilling PLC reported contract revenue of USD 6.4 million (nil Q1), EBITDA USD 1.5 million loss (USD 7.4 million loss in Q1) and a net loss of USD 4.6 million (USD 9.4 million loss in Q1).Revenue efficiency was 100% during the quarter (nil in Q1).Operational uptime was 100% during the quarter (nil in Q1).Contract utilisation was 34.1% during the quarter (nil in Q1).Contract backlog at the end of Q2 was approximately USD 19.4 million (USD 13.8 million Q1).Please see attached for the Q2 2020 report.A digital presentation will be held today, 12 August 2020, at 13:00 UK time (14:00pm CET / 08:00 EST). The presentation will be available for download on the Investor Relations section (go to “Press Releases”) at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation.To join the...

Continue reading

ABN AMRO reports net loss of EUR 5 million for Q2 2020

ABN AMRO reports net loss of EUR 5 million for Q2 2020 Breakeven net result (EUR 5 million negative) reflects high impairmentsContinued engagement with clients to support them through Covid-19Good operational performance; net interest income under pressure from low interest ratesCosts continue to benefit from cost-saving programmesRobust capital position, with a CET1 ratio of 17.3% (Basel III) and around 14% (Basel IV)Bank to focus on Netherlands and Northwest EuropeSignificant risk reduction in global sectors is expected to be capital accretive over timeRobert Swaak, CEO, comments:‘When I started as CEO of ABN AMRO I set four priorities: navigate the bank through the Covid-19 crisis, review the strategy, focus on our licence to operate, and further enhance the bank’s culture. We have made progress in all areas, including the strategy...

Continue reading

ABN AMRO rapporteert nettoverlies van EUR 5 miljoen over Q2 2020

ABN AMRO rapporteert nettoverlies van EUR 5 miljoen over Q2 2020Break-even nettoresultaat (EUR 5 miljoen negatief) weerspiegelt hoge kredietvoorzieningenVoortdurende betrokkenheid bij klanten om hen bij te staan gedurende Covid-19Goed operationeel resultaat; netto rentebaten onder druk door lage renteKosten blijven dalen dankzij kostenbeheersingRobuuste kapitaalpositie; Basel III CET1 ratio van 17,3% en Basel IV CET1 ratio circa 14%Bank zal zich focussen op Nederland en Noordwest EuropaSignificante risicoreductie in wereldwijde sectoren zal naar verwachting in de komende jaren de kapitaalpositie versterkenRobert Swaak, CEO:‘Toen ik als CEO van ABN AMRO begon, heb ik vier prioriteiten gesteld: de bank door de Covid-19 crisis loodsen, de strategie onder de loep nemen, ons focussen op onze licence-to-operate, en de cultuur van de bank verder...

Continue reading

Hexagon Composites ASA: Results for the second quarter and first half year 2020

In the second quarter of 2020, Hexagon Group generated NOK 683 (882) million in revenues and recorded an operating profit before depreciation (EBITDA) of NOK 19 (62) million. Profitability was reduced by the impacts of the global pandemic and resulting macro factors, particularly in Agility Fuel Solutions and Hexagon Mobile Pipeline businesses. Hexagon Ragasco experienced a strong quarter.The first half of 2020 provided revenues of NOK 1,508 (1,704) million and an operating profit before depreciation (EBITDA) of NOK 56 (212) million. The 2019 comparative EBITDA included overall positive impacts related to the Agility Fuel Solutions transaction of NOK 62 million, in the first quarter of that year.The financial impacts of COVID-19 were most apparent in the second quarter, especially impacting transit bus demand in North America and Europe...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.